The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploratory study of prognostic factors in mCRPC patients who administered enzalutamide focusing on early PSA decline and PSA kinetics at PSA progression: Results of retrospective multicenter study.
 
Yoshiyuki Miyazawa
No Relationships to Disclose
 
Nobuaki Shimizu
No Relationships to Disclose
 
Yutaka Takezawa
No Relationships to Disclose
 
Toshiyuki Nakamura
No Relationships to Disclose
 
Takeshi Miyao
No Relationships to Disclose
 
Hiroshi Nakayama
No Relationships to Disclose
 
Sota Kurihara
No Relationships to Disclose
 
Takahiro Syuto
No Relationships to Disclose
 
Masashi Nomura
No Relationships to Disclose
 
Yoshitaka Sekine
No Relationships to Disclose
 
Hidekazu Koike
No Relationships to Disclose
 
Hiroshi Matsui
No Relationships to Disclose
 
Yasuhiro Shibata
No Relationships to Disclose
 
Kazuhiro Suzuki
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Daiichi Sankyo; Janssen; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Takeda
Research Funding - Astellas Pharma; Daiichi Sankyo; Takeda